REDHILL BIOPHARMA LTD - ADR: Diferență între versiuni
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei REDHILL BIOPHARMA LTD - ADR listata cu simbolul US.RDHL ==Descriere companie== Redhill Biopharma Ltd (https://www.redhillbio.com/) is an Israel-basedis a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The Company promotes three gastrointestinal drugs in the US: Movantik, Talicia and Aemcolo. Key programs in it pipeline of late-stage clinical assets include: opaganib (Yeliva) and RHB-107 for multip...) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 1: | Linia 1: | ||
Pagina dedicata companiei REDHILL BIOPHARMA LTD - ADR listata cu simbolul US.RDHL | Pagina dedicata companiei [[REDHILL BIOPHARMA LTD]] - ADR listata cu simbolul US.RDHL | ||
==Descriere companie== | ==Descriere companie== | ||
Versiunea curentă din 3 octombrie 2024 02:46
Pagina dedicata companiei REDHILL BIOPHARMA LTD - ADR listata cu simbolul US.RDHL
Descriere companie[edit | ]
Redhill Biopharma Ltd (https://www.redhillbio.com/) is an Israel-basedis a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The Company promotes three gastrointestinal drugs in the US: Movantik, Talicia and Aemcolo. Key programs in it pipeline of late-stage clinical assets include: opaganib (Yeliva) and RHB-107 for multiple indications including COVID-19, RHB-204 for pulmonary nontuberculous mycobacteria (NTM) disease and RHB-104 for Crohn's disease.
Grafic actiuni companie[edit | ]